To include your compound in the COVID-19 Resource Center, submit it here.

Neurocrine leaps on strong Ingrezza sales

Neurocrine Biosciences Inc. (NASDAQ:NBIX) rose $11.85 (19%) to $72.78 on Thursday after reporting strong sales of Ingrezza valbenazine in

Read the full 194 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE